FDA regulates prescription drug advertising under the authority of the Federal Food, Drug, and Cosmetic Act (FDCA) and the implementing regulations. In 2018, after observing an increase in quantitative presentations of efficacy and risk information

Continue Reading Key updates from FDA’s latest guidance on presenting efficacy and risk data in DTC promotion


Written by:Meghan Carey, Jessica McKinney, Rommy Hage

The Securities and Exchange Commission (SEC) adopted amendments to Form Private Fund (Form PF), the confidential reporting form for certain SEC-registered investment advisers to private

Continue Reading Guest Blog: SEC significantly expands Form PF reporting requirements for private equity fund advisers and large hedge fund advisers

Written by: Christopher Cullen, Sam Tyner-Monroe, Tony Samp, Bennett Borden, Danny Tobey. Coran Darling

The Select Committee on Artificial Intelligence (AI) of the National Science and Technology Council has released its latest update to the

Continue Reading Guest Blog: The US National AI R&D Strategic Plan 2023: A comprehensive look into the future of AI